SCHEMBL8710846

SCHEMBL8710846

CCCS(=O)(=O)OC(C)C

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
CA2 P00918 2/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14778878 0.86 ALDH1A1 (0.50) ALDH1A1CA2CA1CA9
Pyrrole SCHEMBL29204093 0.85 ALDH1A1 (0.33) ALDH1A1
SCHEMBL17922766 0.85 ALDH1A1 (0.40) ALDH1A1CA2CA1CA9
SCHEMBL14778297 0.84 CA2 (0.42) ALDH1A1CA2CA1CA9
SCHEMBL576042 0.84 ALDH1A1 (0.32) ALDH1A1CA2CA1CA9
SCHEMBL28150641 0.81 CA2 (0.47) CA2CA1CA9
SCHEMBL28014312 0.81 CA2 (0.47) CA2CA1CA9
SCHEMBL28224982 0.81 CA2 (0.47) CA2CA1CA9
SCHEMBL14836923 0.81 ALDH1A1 (0.46) ALDH1A1CA2CA1CA9
SCHEMBL30350824 0.81 ALDH1A1 (0.46) ALDH1A1CA2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117836265-A Organic compound and application thereof, passivation film, solar cell and power utilization device 宁德时代新能源科技股份有限公司 2024-04-05 CN disclosed
WO-2022042577-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND 北京普祺医药科技有限公司 2022-03-03 WO disclosed
US-20170260124-A1 NO- AND H2S- RELEASING COMPOUNDS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK 2017-09-14 US disclosed
WO-2016111210-A1 COMPOSITION FOR FORMING SILICON-CONTAINING FILM AND PATTERN FORMING METHOD USING SAID COMPOSITION JSR株式会社 2016-07-14 WO disclosed
US-20140221316-A1 NO- AND H2S- RELEASING COMPOUNDS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2014-08-07 US disclosed
CN-102459188-A Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors CHEMIZON BEIJING LTD 2012-05-16 CN disclosed
CN-100519681-C Antifogging treatment liquid and method for producing same, antifogging article and method for producing same SEIKO EPSON CORP (JP) 2009-07-29 CN disclosed
CN-1886477-A Anti-fogging treatment liquid, production method therefor, anti-fogging article and production method therefor SEIKO EPSON CORP (JP) 2006-12-27 CN disclosed
US-5717124-A Process for preparation of oxyglutaric acid ester derivatives UBE INDUSTRIES, LTD. (JP) 1998-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221316-A1 NO- AND H2S- RELEASING COMPOUNDS PTGS1, NOS2, NOS1 ALDH1A1 363/4885CA2 1378/4885CA1 1550/4885
US-20170260124-A1 NO- AND H2S- RELEASING COMPOUNDS NOS2, NOS3, NOS1 ALDH1A1 961/4885CA2 1842/4885CA1 2153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.